At Home Superstores Make Large Donation to LLS

Home décor superstore At Home announced today that the company has made a $150,440 donation to the Leukemia & Lymphoma Society (LLS) to fund breakthrough research into all forms of blood cancer as they affect people around the world.

Throughout the month of September, At Home employees at locations across the United States collected customer donations ranging from $1 to $5 to $10 at the check-out register.

"This donation will go a long way to support the great work The Leukemia & Lymphoma Society is doing in the fight against blood cancer," said Lee Bird, chief executive officer of At Home. "We are thrilled by the generosity of our At Home customers and team members who came together to help surpass our expectations for At Home's first national charitable campaign."

At Home also sponsored the LLS Light the Night Walks in cities all over the country in an effort to raise even more money for the charity.

"Our partnership with At Home is helping to bring us closer to our vision of a world without blood cancers," said Louis J. DeGennaro, PhD, LLS president and chief executive officer. "Together, we are having an impact. LLS has invested more than $1 billion in research to advance new therapies for blood cancer patients. Funds raised by At Home will help LLS invest in research to advance new treatments, like targeted therapies that zero in on cancer cells and kill them, and immunotherapies that use a patient's own immune system to fight cancer," said DeGennaro.

Source: PR Newswire

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap